Perspectives in Lung Cancer

Venue: The Thistle Tower Hotel

Location: London,

Event Date/Time: Dec 06, 2001 End Date/Time: Dec 08, 2001
Early Registration Date: Nov 21, 2001
Report as Spam


It is our great pleasure to invite you to come to London to attend this European Conference: Perspectives in Lung Cancer.

The purpose of this Conference is to update specialists in the field with the latest information on the treatment of lung cancer. This information will be based on the most recent developments in the specific areas of lung cancer by specialists who will discuss the last two years of reported results of research in these areas. The faculty of international experts will guarantee an up-to-date state, of the art program with emphasis on recent data in diagnosis and treatment of lung cancer. More specifically, we look forward to their views on new developments, such as screening with molecular markers, endobronchial approaches, recommendations in cases of more than one separate lesion, and cases of minimal residual disease. There will be ample opportunity for questions during the discussion periods and informal contacts with the faculty.

We would very much like to welcome you to London because we expect both, London before Christmas and the conference to be very rewarding and enjoyable experiences.

Pieter E. Postmus, Chairman
University Hospital Vrije Universiteit
Amsterdam, The Netherlands

Who Should Attend

This educational program is intended for lung specialists, medical oncologists, radiation oncologists, thoracic surgeons, and other physicians in active clinical practice interested and/or involved in the management of patients with lung cancer. No specialized knowledge or skills other than a general familiarity with cancer and its treatment is required for successful participation in this program.


This conference has been submitted to ESMO for accreditation. Participants will receive a certificate of attendance at the end of the conference.

Heinrich D. Becker
Clinic for Chest Diseases
Heidelberg, Germany

Lucio Crinò
Bellaria Hospital
Bologna, Italy

Ronald A.M. Damhuis
Rotterdam Cancer Registry
Rotterdam, The Netherlands

Wilfried Eberhardt
West German Cencer Center
University of Essen Medic School
Essen, Germany

Giuseppe Giaccone
Vrije Universiteit Medical Center
Amsterdam, The Netherlands

Anna Gregor
University of Edinburgh
Edinburgh, United Kingdom

Dominique Grunenwald
Institut Mutualiste Montsouris
Paris, France

Heine H. Hansen
The Finsen Center
National University Hospital
Copenhagen, Denmark

Peter Harper
Guy’s Hospital
London, United Kingdom

Fred R. Hirsch
University of Colorado Cancer Center
Denver, Colorado

Thierry Le Chevalier
Institut Gustave Roussy
Villejuif, France

Cécile Le Péchoux
Institut Gustave Roussy
Villejuif, France

James L. Mulshine
National Cancer Institute
Bethesda, Maryland, United States

Ugo Pastorino
Istituto Europeo di Oncologia
Milano, Italy

Pieter E. Postmus
Vrije Universiteit Medical Center
Amsterdam,The Netherlands

Rafael Rosell
Hospital Germans Trias I Pujol
Barcelona, Spain

Pierre Rocmans
Erasmus University Hospital
Brussels, Belgium

Giorgio Scagliotti
University of Turin
Turin, Italy

Egbert F. Smit
University Hospital
Vrije Universiteit,
Amsterdam, The Netherlands

Tom G. Sutedja
Vrije Universiteit Medical Center
Amsterdam, The Netherlands

Maurizio Tonato
Policlinico Hospital
Perugia, Italy


Friday, December 7, 2001

9:00 Welcome and introduction
Pieter E. Postmus

Session I: General

9:10 Clinical epidemiology of NSCLC
Ronald A. M. Damhuis

9:35 Pathology and Biology of Preneoplastic Bronchial Lesions
with relevance to Early Detection of Lung Cancer
Fred R. Hirsch

10:00 Screening for early lung cancer
James L. Mulshine

10:25 Endobronchial detection and treatment of early lung cancer
Tom Sutedja

10:50 Coffee Break

Session II: Non Small Cell Lung Cancer Surgical

13:15 Surgical staging and new methods for staging of NSCLC
Dominique Grunenwald

13:40 Surgical approach for clinically operable lesions
Pierre Rocmans

14:05 Management of more than one lesion in the lung
Ugo Pastorino

14:30 Role of postoperative (chemo)therapy in NSCLC
Maurizio Tonato

14:55 Radiotherapy for unfit patients with resectable tumors and
post operative radiotherapy guidelines
Paul van Houtte

15:20 Tea time

Session III: Small Cell Lung Cancer

15:50 Staging of small cell lung cancer
Heine H. Hansen

16:10 Therapy LD
Cécile Le Péchoux

16:40 Therapy ED
Desmond N. Carney

17:00 Adjournment

Saturday, December 8, 2001

8:30 Greetings and announcements

Session IV: NSCLC: Chemotherapy

8:35 Chemotherapy –platinum based overview
Lucio Crino

9:00 Chemotherapy – non-platinum based overview
Peter Harper

9:25 Combined Modality for stage IIIA
Wilfried Eberhardt

9:50 Combined modality for stage IIIB
Thierry Le Chevalier

10:15 Patient tailored chemotherapy for (N)SCLC
Rafael Rosell

10:40 Refreshment Break

Session V: Palliative Care

13:15 Treatment of CNS metastases
Anna Gregor

13:40 Palliation by endobronchial treatment
Heinrich Becker

14:05 Has chemotherapy a role for palliation of elderly and/or unfit patients
Giorgio Scagliotti

14:30 Tea Time

15:00 Management of relapsed lung cancer
Egbert F. Smit

15:25 Tyrosyne Kinase Inhibitors for NSCLC
Giuseppe Giaccone

15:50 Discussion / Q&A

16:00 Adjournment


Additional Information

REGISTRATION INFORMATION: *ESMO-Member Non-Member Payment received on or before December 1, 2001 US$ 399 US$ 449 Payment received after December 1, 2001 and on-site US$ 499 US$ 549 *Must provide ESMO membership number. Registration fees can be paid by credit card (Master/Eurocard, Visa, AMEX) or by check in US Dollars ONLY. Make all checks payable to Imedex. If you are paying by credit card, you may fax the registration form, call in your registration, or register online at To pay via wire transfer, please add US $25 to the registration fee and wire to: (outside the US) Clearing bank: The Chase Manhattan Bank, New York, Swift Code: CHASUS33, Acct: 134734580 (inside the US) ABA Routing No. 021000021. Include the attendee’s full name and the name of the conference: Euro Lung Cancer 2001. A photocopy of payment must be sent to the conference secretariat together with the registration form. Italian Participants: Depha Congress S.r.l has been appointed as the official agency for government authorization for Italian participants. You may contact them at, Depha Congress S.r.l. Via Garofalo n 4, 20133 Milano, Phone: ++39, Fax: ++39.0270.63.92.94 REGISTRATION FEE INCLUSIONS Included in the registration fees are attendance to scientific sessions and satellite symposia, conference materials, certificate of attendance, and refreshment breaks listed in the program. CONFERENCE LANGUAGE The conference language is English. No translation will be provided. HOTEL ACCOMMODATION: Thistle Tower St. Katharine’s Way London E1W 1LD +44 020 7481 2575 +44 020 7488 1667 Situated in the hear of the business district of London, the Thistle hotel is nestled next to the Tower Bridge and the Tower of London and it overlooks the unique St Katharine’s Dock. For the convenience of conference attendees, a limited number of rooms have been reserved at the Thistle Tower Hotel at a reduced rate of £142.00 per night (inclusive of VAT) executive double or twin for single occupancy. Use the registration form included to book rooms; do not call the hotel directly. The conference rate may not be guaranteed outside the conference dates. Five Easy Ways to register ONLINE… FAX Us……CALL Us……Mail Us……Online